Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: GermlineBRCAmutation carriers and wild-typeBRCApancreatic ductal adenocarcinoma: Pancreatic Cancer, PARP Inhibitor, Cisplatin
2018
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
35
References
0
Citations
NaN
KQI